Together, these results support that, following IR or TMZ treatment, p53 promotes the cellular accumulation of PUMA that subsequently binds to and inactivates MCL-1, and thereby creates an exclusive dependence on BCL-XL for GBM survival (Supplementary Fig. 3B). Here, BCL2L1 is linked to glioblastoma.